Comparison of two different dose combinations of calcipotriol/ hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body

European Journal of Dermatology

Volumn 20, Issue 5, 2010, Pages 585-589

  Ortonne, Jean Paul ^a   Noerrelund, Kirsten Lykke ^b   Papp, Kim ^c   Van Herpe, Lydia ^d   Sebastian, Michael ^e   Herrera, Enrique ^d   Bodalia, Bhavesh ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b LEO PHARMA A S   (Denmark)

^c PROBITY MEDICAL RESEARCH   (Canada)

^d Center for Dermatology and Clinical Trials ^*  (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Body; Calcipotriol; Combination therapy; Face; Hydrocortisone; Psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; CALCIPOTRIOL; CALCIPOTRIOL PLUS HYDROCORTISONE; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYSIPELAS; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; DRUG COMBINATIONS; FACE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956912609     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1013     Document Type: Article

References (24)

1. Farber EM, Nall L. Epidemiology: Natural history and genetics. In: Roenigk Jr HH, Maibach HI, eds. Roenigk and Maibach's Psoriasis. New York: Marcel Dekker, 1998: 107-57.
2. Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology 2006; 212: 327-37.
3. Barker J. Psoriasis. Eur J Dermatol 2007; 17: 563-4.
4. Berth-Jones J, Dodd WA, Ganpule M, Griffiths WA, Haydey RP, et al. A multi-centre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266-71.
5. Tham SN, Lim KC, Cheong WK. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994; 131: 673-7.
6. Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-43.
7. Kragballe K, Gjertsen BT, de Hoop D, Karlsmark T, van de kerkhof PCM, Larko O, et al. Double-blind right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-6.
8. Kragballe K, Fogh K, Soegaard H. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Acta Derm Venereol 1991; 71: 475-8.
9. Ramsay CA, Berth-Jones J, Brundin G, Cunliffe WJ, Dubertret L, van de Kerkhof PCM, et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-4. (Pubitemid 24249641)
10. Poyner T, Hughes JW, Dass BK, Adnitt PI. Long-term use of topical calcipotriol in chronic plaque psoriasis. J Dermatol Treat 1993; 4: 173-7. (Pubitemid 24031293)
11. Ellis JP, Griffiths WAD, Klaber MR. Long-term treatment of chronic plaque psoriasis with calcipotriol ointment in patients unresponsive to short contact dithranol. Eur J Clin Res 1995; 7: 247-57.
12. British National Formulary 44. September 2002. British Medical Association, Royal Pharmaceutical Society of Great Britain.
13. Kerscher MJ, Hart H, Korting HC, Stalleicken D. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. Int J Clin Pharmacol Ther 1995; 33: 187-9.
14. Katz HI, Prawer SE, Watson MJ, Sull TA, Peets EA. Mometasone furoate ointment 0.1% vs. hydrocortisone ointment 1.0% in psoriasis. Atrophogenic potential. Int J Dermatol 1989; 28: 342-4.
15. el-Hefnawi H, el-Shiemy S, Paris R, Tadros SS. Double-blind paired comparison clinical trial of halcidonide and hydrocortisone. Cutis 1978; 22: 97-9.
16. Papp KA, Guenther L, Boyden B, Grønhøj Larsen F, Harvima RJ, Guilhou JJ, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003; 48: 48-54.
17. Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002; 82: 131-5.
18. Katoh N, Kishimoto S. Combination of calcipotriol and clobetasol propinate as a premixed ointment for the treatment of psoriasis. Eur J Dermatol 2003; 13: 382-4. (Pubitemid 36963099)
19. Parslew R, Traulsen J. Efficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patients with psoriasis vulgaris. Eur J Dermatol 2005; 15: 37-9. (Pubitemid 40254621)
20. Jemec GBE, Ganslandt C, Ortonne JP, Poulin Y, Burden AD, de Unamuno P, et al. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis. J Am Acad Dermatol 2008; 59: 455-63.
21. Guenther L, Campazard F, van de Kerkhof PCM, Snellman E, Kragballe K, Chu AC, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris : a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002; 147: 316-23.
22. Claréus BW, Houwing R, Sindrup JH, Wigchert S. The DESIRE study - psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily practise. Eur J Dermatol 2009; 19: 581-5.
23. Van de Kerkhof PCM, Murphy GM, Austad J, Ljungberg A, Cambazard F, Duvold L. Psoriasis of the face and flexures. J Dermatol Treat 2007; 18: 351-60.
24. Lebwohl MG, Tan M-H, Meador SL, Singer G. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001; 44: 77-82. (Pubitemid 32110566)